POTS and Dysautonomia: Beyond the Heart-Rate Cutoff

7 days ago

7 min read

Updated: 20 hours ago

This Dysautonomia Awareness Month, a new international expert consensus is bringing scientific recognition to symptoms, overlapping conditions, and everyday challenges that patients have been describing for years.

Imagine experiencing debilitating dizziness, brain fog, palpitations, and exhaustion whenever you stand, only to discover that your heart rate falls two beats per minute short of the threshold required for a POTS diagnosis.

Your symptoms are real. Your ability to function is affected. But where does that leave you medically?

This is one of the questions addressed by a major new international consensus published in The American Journal of Medicine in 2026.

The paper brings together 40 experts and contributors from seven countries, including clinicians from multiple specialties and patient advocacy representatives. Using a structured consensus process, they reached agreement on 31 statements covering the diagnosis, physiology, treatment, and functional impact of POTS and related autonomic disorders.

Every statement achieved at least 92.5% agreement, and 24 received unanimous support.

For people living with POTS, hypermobility, MCAS, ME/CFS, Long COVID, or unexplained orthostatic symptoms, the findings offer an important development in how autonomic dysfunction is understood.

Beyond the POTS Heart-Rate Threshold

To understand why this consensus matters, it helps to look at what happens when we stand.

Our autonomic nervous system continuously regulates processes such as heart rate, blood pressure, digestion, and temperature. When we move upright, gravity shifts blood toward the abdomen and legs. The body responds by adjusting blood vessel constriction and heart rate to maintain circulation, including blood flow to the brain.

When these responses become disrupted, standing can trigger dizziness, palpitations, weakness, fatigue, cognitive difficulties, and other symptoms of orthostatic intolerance.

POTS is one recognized form of this dysfunction.

Under established diagnostic criteria, POTS involves chronic orthostatic symptoms alongside a sustained heart-rate increase of at least 30 beats per minute in adults or 40 beats per minute in adolescents during standing or tilt testing, without significant orthostatic hypotension and with other causes considered.

These criteria are important for identifying and studying POTS. But they cannot describe every form of autonomic dysfunction.

Someone may experience severe orthostatic symptoms while falling below the required heart-rate increase during testing. Others may have physiological abnormalities that are not adequately reflected by their heart-rate response.

The international panel unanimously agreed that failing to meet the POTS heart-rate threshold does not rule out clinically significant autonomic dysfunction.

The experts also recognized that patients with substantial symptoms and functional impairment deserve appropriate investigation, treatment, and consideration for accommodations.

The paper discusses the provisional term non-POTS dysautonomia for some of these presentations. It is a proposed way of describing a clinical gap, rather than a new universally established diagnosis.

For patients who have struggled to obtain recognition because their test results fall just outside the criteria, this is a significant message: a heart-rate cutoff should not be the only measure of autonomic health.

What Causes POTS and Dysautonomia?

One of the most interesting aspects of the consensus is its recognition that POTS is a multisystem physiological condition with several possible underlying mechanisms.

Rather than assuming that every patient has the same problem, the paper describes different processes that may contribute to similar symptoms.

Low blood volume and reduced cardiac preload. Some patients have reduced circulating blood volume or insufficient blood returning to the heart when upright. This can affect cardiovascular function and contribute to compensatory increases in heart rate.

Altered sympathetic nervous system activity. Changes in autonomic signalling may produce excessive sympathetic activation, influencing heart rate, blood vessel responses, and other physiological processes.

Reduced cerebral blood flow. When circulation to the brain is affected during upright posture, patients may experience dizziness, visual disturbances, difficulty concentrating, and brain fog.

Small fiber neuropathy. Small nerve fibres help regulate autonomic functions, including blood vessel constriction. Dysfunction in these nerves may contribute to impaired circulatory responses.

Immune and mast cell-related mechanisms. The consensus also discusses autoimmune processes, mast cell hyperactivity, and other possible immune-related contributors, alongside emerging research into endothelial dysfunction and neuroinflammation.

These mechanisms are not necessarily present in every patient, and several may interact.

This helps explain why two people with POTS can experience very different symptoms, or why someone may have significant autonomic dysfunction without displaying the typical heart-rate response.

Understanding these differences is also essential for developing more precise diagnostic tools and treatments.

Why POTS Often Overlaps With hEDS, MCAS and Long COVID

For the Paramotion community, another important part of the consensus is its recognition of the conditions frequently associated with POTS and dysautonomia.

These include hypermobile Ehlers-Danlos syndrome (hEDS), hypermobility spectrum disorders (HSD), mast cell activation syndrome (MCAS), small fiber neuropathy, migraine, ME/CFS, and Long COVID.

These associations matter because autonomic symptoms rarely exist in isolation for many patients.

Hypermobility and circulation

People with hEDS or HSD may experience joint instability, pain, fatigue, and orthostatic intolerance.

Researchers are investigating how connective tissue characteristics, vascular function, and circulatory regulation may contribute to autonomic symptoms in this population.

For example, difficulties maintaining effective blood return to the heart when upright may contribute to dizziness, palpitations, and fatigue.

MCAS and immune-related mechanisms

Mast cells release substances that influence inflammation, blood vessel behaviour, and other physiological responses.

The consensus recognizes mast cell activity and immune-related processes as possible contributors to certain forms of autonomic dysfunction.

This is particularly relevant for people who experience overlapping symptoms involving circulation, digestion, skin reactions, and other body systems.

ME/CFS, Long COVID and small fiber neuropathy

Autonomic dysfunction is also associated with ME/CFS and Long COVID, where orthostatic intolerance may occur alongside profound fatigue, cognitive difficulties, and post-exertional malaise.

Small fiber neuropathy is another important area of investigation because these nerve fibres participate in autonomic regulation.

The precise relationships between these conditions remain an active research area. However, their inclusion in the international consensus reinforces the importance of considering associated diagnoses and possible shared mechanisms during clinical assessment.

For patients managing several interconnected conditions, the broader physiological picture can be just as important as any single diagnosis.

POTS Is Physical, Not Psychological

One of the clearest and most significant findings concerns the physical nature of POTS.

All 40 experts agreed that POTS is an autonomic nervous system disorder and is not caused by anxiety, mood disorders, fear of standing, or avoidance behaviours.

The panel also agreed that POTS and other autonomic disorders are distinct from functional neurological disorders, although different conditions can coexist.

This is an important statement for people who have experienced palpitations, dizziness, shaking, fatigue, and cognitive difficulties, only to have their symptoms attributed to psychological causes.

These symptoms can arise from measurable disturbances in autonomic and circulatory regulation.

Anxiety or other mental health conditions may coexist with POTS, but they do not explain away the underlying autonomic disorder.

The consensus provides a clear scientific position: POTS is a physical medical condition that requires appropriate clinical assessment and treatment.

For many patients, this is recognition of something they have been trying to communicate for years.

What the Consensus Says About Treatment and Exercise

Recognizing the complexity of dysautonomia also changes how treatment should be approached.

The experts support a combination of non-pharmacological and pharmacological strategies tailored to individual symptoms and physiological needs.

Measures such as appropriate fluid and salt intake, compression garments, and management of symptom triggers can help support circulation and orthostatic tolerance when medically suitable.

Importantly, the consensus also supports timely consideration of medication when these measures are insufficient.

The paper discusses treatments including beta blockers, ivabradine, midodrine, pyridostigmine, and fludrocortisone. These medications act through different mechanisms, such as influencing heart rate, vascular tone, or blood volume, and their suitability depends on the patient's presentation.

Exercise must be individualized, especially when PEM is present

The consensus also addresses a particularly important issue for patients living with overlapping conditions.

All 40 experts agreed that seated and recumbent exercise should be adapted to individual symptoms, exercise capacity, and the presence and severity of post-exertional malaise (PEM).

PEM is a worsening of symptoms following exertion and is a defining feature of ME/CFS. It can also occur in Long COVID.

For some people with POTS, carefully structured physical activity may improve conditioning and orthostatic tolerance. However, the presence of PEM changes how activity must be approached, because exertion can trigger a significant and sometimes prolonged worsening of symptoms.

This makes individualized assessment essential.

For Paramotion, the findings reinforce the importance of developing movement and rehabilitation strategies around the person's actual physiology, associated conditions, symptoms, and capacity.

Effective rehabilitation begins with understanding what the body can tolerate and why.

Why Recognition Matters for Disability and Daily Life

The consensus goes beyond diagnosis and treatment to address something equally important: the effect of dysautonomia on everyday functioning.

The experts unanimously recognized that POTS and related autonomic dysfunction can cause substantial functional impairment and reduced quality of life.

For someone living with severe orthostatic intolerance, ordinary activities such as showering, cooking, commuting, attending school, or working at a desk may require significant effort or become difficult to sustain.

These limitations can occur in people who meet the formal POTS criteria and in those with significant autonomic dysfunction who do not.

The panel supported appropriate workplace and educational accommodations, recognizing that functional impairment should be considered alongside diagnostic findings.

The experts also acknowledged that autonomic conditions may affect employment and can justify disability benefits for patients who meet the relevant eligibility requirements.

The paper highlights the need for clearer diagnostic classifications, better medical education, improved access to multidisciplinary care, and further research into objective biomarkers and targeted treatments.

These priorities matter because improved recognition can influence whether patients receive suitable clinical support and practical accommodations.

From Scientific Recognition to Better Care

The next challenge is turning this expert agreement into better clinical practice.

Recognizing the different mechanisms behind autonomic dysfunction opens the door to more precise assessments, more targeted treatments, and rehabilitation strategies that reflect each person's physiological needs.

At Paramotion, this is central to how we approach movement and rehabilitation, particularly for people living with hypermobility, POTS, and overlapping chronic conditions. Understanding circulation, orthostatic tolerance, fatigue, and post-exertional responses helps inform what kind of movement is appropriate, how it can be adapted, and when recovery needs to take priority.

The international consensus strengthens the case for an individualized approach, while highlighting the need for continued research and better access to multidisciplinary care.

The goal is to use that understanding to provide better care. 👉 [Book your Free consultation call here!!] we’ll talk about what’s possible for your body, at your pace.